39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
20 °P sammeln
  • Broschiertes Buch

This compact and innovative book tackles one of the central issues in drug policy: the lack of a coherent conceptual structure for our thinking about drugs. Battin and her contributors lay a foundation for a wiser drug policy by promoting consistency and coherency in the discussion of drug issues and by encouraging a unique dialogue across disciplines. The book is written accessibly with little need for expert knowledge, and will appeal to a diverse audience of philosophers, bioethicists, clinicians, policy makers, law enforcement, legal scholars and practitioners, social workers, and general…mehr

Produktbeschreibung
This compact and innovative book tackles one of the central issues in drug policy: the lack of a coherent conceptual structure for our thinking about drugs. Battin and her contributors lay a foundation for a wiser drug policy by promoting consistency and coherency in the discussion of drug issues and by encouraging a unique dialogue across disciplines. The book is written accessibly with little need for expert knowledge, and will appeal to a diverse audience of philosophers, bioethicists, clinicians, policy makers, law enforcement, legal scholars and practitioners, social workers, and general readers, as well as to students in areas like pharmacy, medicine, law, nursing, sociology, social work, psychology, and bioethics.
Autorenporträt
Margaret P. Battin is Distinguished Professor of Philosophy and Adjunct Professor of Internal Medicine, Division of Medical Ethics, University of Utah. Erik Luna is Professor of Law, University of Utah Arthur G. Lipman is Director of Clinical Pharmacology, University of Utah Paul M. Gahlinger is Adjunct Professor of Family and Preventive Medicine, University of Utah